Keywords: DKD; diabetic kidney disease; RAAS; renin-angiotensin-aldosterone system; ESRD; end-stage renal disease; T1DM; type I diabetes mellitus; T2DM; type II diabetes mellitus; CVD; cardiovascular disease; GFR; glomerular filtration rate; AER; albumin excretion
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: T2DM; type 2 diabetes; IR; insulin resistance; HbA1c; glycated hemoglobin A1c; GLUT-4; glucose transporter4; GLP-1; glucagon-like peptide-1; DPP4; dipeptidyl peptidase; eGFR; estimated glomerular filtration rate; HF; heart failure; UKPDS; United Kingdom P
Keywords: Sleep disorder; Sleep quality; Sleep amount; Type 2 diabetes; Systematic review; Meta-analysis; AHI; apnea-hypopnea index; CI; confidence interval; HbA1c; hemoglobin A1c; MOOSE; meta-analyses and systematic reviews of observational studies; OSA; obstructi
Keywords: RCT; Randomized controlled trial; CVD; Cardiovascular disease; VADT; Veterans Affairs Diabetes Trial; UKPDS; The United Kingdom Prospective Diabetes Study; HbA1c; HemoglobinA1c; BMI; Body mass index; HDL; High density lipoprotein; SD; Standard deviation;
Keywords: ACCORD; Action to Control Cardiovascular Risk in Diabetes; Ang; angiopoietin; ARMD; age-related macular degeneration; BRB; blood-retinal barrier; CRT; central retinal thickness; DARPin; designed ankyrin repeat proteins; DCCT; Diabetes Control and Compli
Keywords: ACCORD; Action to Control Cardiovascular Risk in Diabetes; CI; confidence interval; DA; disc area; DD; disc diameter; DME; diabetic macular edema; ETDRS; Early Treatment Diabetic Retinopathy Study; FIELD; Fenofibrate Intervention and Event Lowering in Dia
Keywords: ACE-I; angiotensin-converting enzyme inhibitor; ARB; angiotension receptor blocker; BMI; body mass index; Cr; creatinine; CVD; cardiovascular disease; DPP-4; dipeptidyl peptidase 4; GAD-65; glutamic acid decarboxylase; GLP-1; glucagon-like peptide 1; GFR;
High-dose metformin (420Â mg/kg daily p.o.) increases insulin sensitivity but does not affect neointimal thickness in the rat carotid balloon injury model of restenosis
Keywords: AICAR; 5-aminoimidazole-4-carboxamide ribonucleotide; AMP; adenosine monophosphate; AMPK; AMP-activated protein kinase; ANOVA; analysis of variance; ATM; ataxia telangiectasia mutated; ATP; adenosine-5â²-triphosphate; CamKK; calcium/calmodulin-dependent
Metformin attenuates ER stress-induced mitochondrial dysfunction
Keywords: AIF; apoptosis inducing factor; AMPK; AMP-activated protein kinase; ASPP2; apoptosis-stimulating protein of p53-2; ADP; adenosine diphosphate; ATP; adenosine triphosphate; CHOP; C/EBP homologous protein; BSA; bovine serum albumin; CRC; calcium retention c
Evaluation of a HbA1c point-of-care analyzer
Keywords: DM; Diabetes Mellitus; HbA1c; glycated hemoglobin; UKPDS; United Kingdom Prospective Diabetes Study; DCCT; Diabetes Control and Complications Trial; IFCC; International Federation of Clinical Chemistry and Laboratory Medicine; Hb; hemoglobin; Micro-TAS; M
Accuracy of Anthropometric Parameters in Identification of High-risk Patients Predicted With Cardiovascular Risk Models
Keywords: Waist-to-hip ratio; Waist-to-height ratio; UKPDS; SCORE; Framingham;
Podocytes and the struggle against glucose toxicity: New targets for treatment?
Keywords: ROS; reactive oxygen species; GBM; glomerular basement membrane; TGFβ1; transforming growth factor β1; ATP; adenosine triphosphate; GLUT1; glucose transporter 1; DCCT; Diabetes Control and Complications Trial; EDIC; Epidemiology of Diabetes Intervention
Contribution of Modeling Approaches and Virtual Populations in Transposing the Results of Clinical Trials into Real Life and in Enlightening Public Health Decisions
Keywords: modeling; simulation; clinical trials; public decision; virtual populations; CEPS; Economic committee of the health products in France (Comité économique des produits de santé); CTV; Technical committe of vaccinations in France (Comité technique des v
Apport de la modélisation et des populations virtuelles pour transposer les résultats des essais cliniques à la vie réelle et éclairer la décision publique
Keywords: modélisation; simulation; essais cliniques; décision publique; populations virtuelles; AMM; autorisation de mise sur le marché; ANAES; Agence nationale d'accréditation et d'évaluation en santé; ANR; Agence nationale de la recherche; CEPS; ComitÃ
Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus
Keywords: ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADVANCE; Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation; CAD; coronary artery disease; CI; confidence interval; CV; cardiovascular; DM; diab
Defining and Achieving Treatment Success in Patients With Type 2 Diabetes Mellitus
Keywords: ACCORD; Action to Control Cardiovascular Risk in Diabetes; ACT NOW; ACTos NOW for the Prevention of Diabetes; ADVANCE; Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release and Controlled Evaluation; BP; blood pressure; CVD; car
A Physiologic and Pharmacological Basis for Implementation of Incretin Hormones in the Treatment of Type 2 Diabetes Mellitus
Keywords: ADA; American Diabetes Association; AE; adverse event; CI; confidence interval; DM; diabetes mellitus; DPP-4; dipeptidyl peptidase 4; EASD; European Association for the Study of Diabetes; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-
Implicaciones del estudio ONTARGET en hipertensión arterial y diabetes tipo 2
Keywords: Bloqueo dual del sistema renina angiotensina; Inhibidores de la enzima de conversión de angiotensina; Antagonistas de los receptores de la angiotensina II; Hipertensión arterial; Diabetes mellitus tipo 2; Dual blockade of the renin-angiotensin system; A
La “memoria metabólica” inducida por la hiperglucemia: el nuevo reto en la prevención de la enfermedad cardiovascular en la diabetes
Keywords: Memoria metabólica; Glicación no enzimática; Estrés oxidativo; Mitocondrias; Complicaciones diabéticas; Metabolic memory; Non-enzymatic glycation; Oxidative stress; Mitochondria; Diabetic complications; AGE; productos finales de glicación avanzada;
La diabetes mellitus entendida como una enfermedad cardiovascular de origen metabólico
Keywords: Diabetes mellitus tipo 2; Resistencia insulÃnica; Enfermedad vascular diabética; Aterotrombosis; Type-2 diabetes mellitus; Insulin resistance; Diabetic vascular disease; Atherothrombosis; ADA; American Diabetes Association; AGE; productos de glucación
Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain
Keywords: Cardiovascular disease; Risk factor; Type 2 diabetes mellitus; UKPDS; SCORE
La diabetes mellitus tipo 2 como enfermedad cardiovascular
Keywords: Diabetes mellitus tipo 2; Obesidad abdominal; Dislipidemia aterogénica; Sintetasa del óxido nÃtrico; Moléculas de adhesión; Type-2 diabetes mellitus; Visceral obesity; Atherogenic dyslipidemia; Nitric oxide synthase; Adhesion molecules; ACVA; acciden
A Pen-and-Paper Coronary Risk Estimator for Office Use With Patients With Type 2 Diabetes
Keywords: CHD; coronary heart disease; HbA1c; hemoglobin A1c; UKPDS; United Kingdom Prospective Diabetes Study;
The Metabolic Syndrome: Concepts and Controversy
Keywords: ACE; American College of Endocrinology/American Association of Clinical Endocrinologists; ADA; American Diabetes Association; BMI; body mass index; CVD; cardiovascular disease; DM; diabetes mellitus; EASD; European Association for the Study of Diabetes; F
Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73
Keywords: UKPDS; Hypoglycemia; Type 2 diabetes
Effect on glycemic control of the addition of 2.5Â mg glipizide GITS to metformin in patients with T2DM
Keywords: ANOVA; analysis of variance; BMI; body mass index; CBC; clinical blood chemistry; FPG; fasting plasma glucose; GITS; gastrointestinal therapeutic system; HBGM; home blood glucose monitoring; HOMA; homeostasis model assessment; UKPDS; UK Prospective Diabet